Search research articles
Contact Us
Filters
Showing results (581-590 of 831) with videos related to
Page
of 84
Sort By:
The Lancet. Oncology
|
March 7, 2018
Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative
Linda Dirven, Terri S Armstrong, Jaishri O Blakeley, et al.
Science Translational Medicine
|
May 24, 2023
Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell-dependent regression of glioblastoma
Thomas Look, Emanuele Puca, Marcel Bühler, et al.
Neuro-Oncology
|
January 8, 2019
PET imaging in patients with brain metastasis-report of the RANO/PET group
Norbert Galldiks, Karl-Josef Langen, Nathalie L Albert, et al.
Acta Neuropathologica
|
June 26, 2009
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann, Jochen Meyer, Jörg Balss, et al.
Cancer Treatment Reviews
|
August 16, 2024
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape
Michael Weller, Jordi Remon, Stefan Rieken, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 30, 2023
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial
Emilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.
The Lancet. Oncology
|
May 15, 2012
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
Wolfgang Wick, Michael Platten, Christoph Meisner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 10, 2023
Theranostics in Neurooncology: Heading Toward New Horizons
Nelleke Tolboom, Antoine Verger, Nathalie L Albert, et al.
Annals of Neurology
|
February 9, 2002
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma
Ulrich Herrlinger, Martin Schabet, Wolfram Brugger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network
Michael Weller, Jörg Felsberg, Christian Hartmann, et al.
Page
of 84
Search research articles
Search
Showing results (581-590 of 831) with videos related to
Sort By:
Page
of 84
The Lancet. Oncology
|
March 7, 2018
Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative
Linda Dirven, Terri S Armstrong, Jaishri O Blakeley, et al.
Science Translational Medicine
|
May 24, 2023
Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell-dependent regression of glioblastoma
Thomas Look, Emanuele Puca, Marcel Bühler, et al.
Neuro-Oncology
|
January 8, 2019
PET imaging in patients with brain metastasis-report of the RANO/PET group
Norbert Galldiks, Karl-Josef Langen, Nathalie L Albert, et al.
Acta Neuropathologica
|
June 26, 2009
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann, Jochen Meyer, Jörg Balss, et al.
Cancer Treatment Reviews
|
August 16, 2024
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape
Michael Weller, Jordi Remon, Stefan Rieken, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 30, 2023
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial
Emilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.
The Lancet. Oncology
|
May 15, 2012
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
Wolfgang Wick, Michael Platten, Christoph Meisner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 10, 2023
Theranostics in Neurooncology: Heading Toward New Horizons
Nelleke Tolboom, Antoine Verger, Nathalie L Albert, et al.
Annals of Neurology
|
February 9, 2002
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma
Ulrich Herrlinger, Martin Schabet, Wolfram Brugger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network
Michael Weller, Jörg Felsberg, Christian Hartmann, et al.
Page
of 84